Brought to you by 
Covidien scoops up Reverse Medical
12 Sep 2014
Executive Summary
Covidien PLC acquired Reverse Medical Corp., which develops vascular disease management devices, for an undisclosed sum. The transaction comes two months after Medtronic Inc. announced it was buying Covidien for $42.5bn in cash and stock, the largest medical device M&A to date.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Covidien scoops up Reverse Medical
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice